MENU
SYRE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Spyre Therapeutics (SYRE) Earnings Date & Reports
Spyre Therapeutics Inc is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (IBD) and rheumatic diseases... Show more
Industry: #Pharmaceuticals Major
A.I. Advisor
published Earnings
SYRE is expected to report earnings to rise 119.44% to -79 cents per share on November 03
Q3'26
Est.
$-0.79
Q2'26
Beat
by $0.40
Q1'26
Missed
by $0.07
Q4'25
Est.
$-0.70
Q3'25
Beat
by $0.62
The last earnings report on August 04 showed earnings per share of -36 cents, beating the estimate of -75 cents. With 37.63K shares outstanding, the current market capitalization sits at 8.20B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
a biopharmaceutical company
Industry Biotechnology
Industry
Pharmaceuticals Major
Address
221 Crescent Street
Phone
+1 617 651-5940
Employees
102
Web
https://www.spyre.com